WallStreetZenWallStreetZen

NASDAQ: CGNX
Cognex Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CGNX

Based on 9 analysts offering 12 month price targets for Cognex Corp

Min Forecast
$38.00-0.26%
Avg Forecast
$47.11+23.65%
Max Forecast
$58.00+52.23%

Should I buy or sell CGNX stock?

Based on 9 analysts offering ratings for Cognex Corp.

Buy
Strong Buy
3 analysts 33.33%
Buy
1 analysts 11.11%
Hold
4 analysts 44.44%
Sell
0 analysts 0%
Strong Sell
1 analysts 11.11%
Although CGNX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CGNX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CGNX stock forecasts and price targets.

CGNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-03
lockedlocked$00.00+00.00%2025-10-31
lockedlocked$00.00+00.00%2025-10-31
lockedlocked$00.00+00.00%2025-10-31
lockedlocked$00.00+00.00%2025-10-08
Goldman Sachs
Top 5%
96
Strong SellMaintains$40.00+4.99%2025-09-16
JP Morgan
Top 45%
56
HoldInitiates Coverage On$45.00+18.11%2025-09-15
UBS
Top 30%
71
Strong BuyMaintains$58.00+52.23%2025-08-01
KeyBanc
Top 5%
96
Strong BuyUpgrades$50.00+31.23%2025-08-01
Citigroup
HoldMaintains$37.00-2.89%2025-07-14

1 of 1

Forecast return on equity

Is CGNX forecast to generate an efficient return?

Company
24.1%
Industry
24.4%
Market
230.27%
CGNX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CGNX forecast to generate an efficient return on assets?

Company
17.93%
Industry
13.63%
CGNX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CGNX earnings per share forecast

What is CGNX's earnings per share in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$0.97+47%
Avg 2 year Forecast
$1.17+77.14%
Avg 3 year Forecast
$1.38+108.76%
CGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CGNX revenue forecast

What is CGNX's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$995.8M+2.48%
Avg 2 year Forecast
$1.1B+10.63%
Avg 3 year Forecast
$1.2B+20.72%
CGNX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CGNX earnings growth forecast

How is CGNX forecast to perform vs Scientific & Technical Instruments companies and vs the US market?

Company
27.74%
Industry
37.23%
Market
42.81%
CGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CGNX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CGNX revenue growth forecast

How is CGNX forecast to perform vs Scientific & Technical Instruments companies and vs the US market?

Company
6.36%
Industry
5.35%
Market
25.31%
CGNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CGNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CGNX vs Scientific & Technical Instrument Stocks

TickerPricePrice TargetUp/downsideConsensus
CGNX$38.10$47.11+23.65%Buy
ESE$212.91$275.00+29.16%Strong Buy
VNT$36.28$46.00+26.79%Strong Buy
BMI$178.54$228.60+28.04%Buy
ST$32.07$36.13+12.64%Buy
View Top Scientific & Technical Instrument Stocks

Cognex Stock Forecast FAQ

Is Cognex Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: CGNX) stock is to Buy CGNX stock.

Out of 9 analysts, 3 (33.33%) are recommending CGNX as a Strong Buy, 1 (11.11%) are recommending CGNX as a Buy, 4 (44.44%) are recommending CGNX as a Hold, 0 (0%) are recommending CGNX as a Sell, and 1 (11.11%) are recommending CGNX as a Strong Sell.

If you're new to stock investing, here's how to buy Cognex stock.

What is CGNX's earnings growth forecast for 2025-2027?

(NASDAQ: CGNX) Cognex's forecast annual earnings growth rate of 27.74% is not forecast to beat the US Scientific & Technical Instruments industry's average forecast earnings growth rate of 37.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.

Cognex's earnings in 2025 is $110,124,000.On average, 24 Wall Street analysts forecast CGNX's earnings for 2025 to be $162,603,627, with the lowest CGNX earnings forecast at $142,894,097, and the highest CGNX earnings forecast at $175,977,951. On average, 24 Wall Street analysts forecast CGNX's earnings for 2026 to be $195,938,879, with the lowest CGNX earnings forecast at $169,341,069, and the highest CGNX earnings forecast at $260,447,368.

In 2027, CGNX is forecast to generate $230,916,592 in earnings, with the lowest earnings forecast at $197,095,306 and the highest earnings forecast at $292,123,399.

What is CGNX's revenue growth forecast for 2025-2027?

(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 6.36% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 5.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.

Cognex's revenue in 2025 is $971,705,000.On average, 24 Wall Street analysts forecast CGNX's revenue for 2025 to be $166,887,433,272, with the lowest CGNX revenue forecast at $156,855,014,059, and the highest CGNX revenue forecast at $175,139,961,205. On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $180,167,902,675, with the lowest CGNX revenue forecast at $168,603,637,294, and the highest CGNX revenue forecast at $201,285,256,849.

In 2027, CGNX is forecast to generate $196,592,511,477 in revenue, with the lowest revenue forecast at $180,503,098,773 and the highest revenue forecast at $214,357,904,671.

What is CGNX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CGNX) forecast ROA is 17.93%, which is higher than the forecast US Scientific & Technical Instruments industry average of 13.63%.

What is CGNX's Price Target?

According to 9 Wall Street analysts that have issued a 1 year CGNX price target, the average CGNX price target is $47.11, with the highest CGNX stock price forecast at $58.00 and the lowest CGNX stock price forecast at $38.00.

On average, Wall Street analysts predict that Cognex's share price could reach $47.11 by Nov 3, 2026. The average Cognex stock price prediction forecasts a potential upside of 23.65% from the current CGNX share price of $38.10.

What is CGNX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CGNX) Cognex's current Earnings Per Share (EPS) is $0.66. On average, analysts forecast that CGNX's EPS will be $0.97 for 2025, with the lowest EPS forecast at $0.85, and the highest EPS forecast at $1.05. On average, analysts forecast that CGNX's EPS will be $1.17 for 2026, with the lowest EPS forecast at $1.01, and the highest EPS forecast at $1.55. In 2027, CGNX's EPS is forecast to hit $1.38 (min: $1.18, max: $1.74).

What is CGNX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CGNX) forecast ROE is 24.1%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.